MNNAX
Price
$66.41
Change
-$0.70 (-1.04%)
Updated
Jul 13 closing price
Net Assets
582.55M
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

MNNAX vs VFFSX

MNNAX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
MNNAX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNNAX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. MNNAX (583M). VFFSX pays higher dividends than MNNAX: VFFSX (1.08) vs MNNAX (0.13). MNNAX was incepted earlier than VFFSX: MNNAX (30 years) vs VFFSX (10 years). MNNAX (1.24) is less costly to investors than VFFSX (0.01). MNNAX is a more actively managed with annual turnover of: 88.00 vs. VFFSX (2.00). MNNAX has a lower initial minimum investment than VFFSX: MNNAX (2500) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. MNNAX (13.02). VFFSX return over 5 years is better than : 73.48 vs. MNNAX (24.51).
MNNAXVFFSXMNNAX / VFFSX
Total Expense Ratio1.240.0112,400%
Annual Report Gross Expense Ratio1.240.0112,400%
Fund Existence30 years10 years-
Gain YTD15.07210.685141%
Front Load6%N/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets583M1.67T0%
Annual Yield % from dividends0.131.0812%
Returns for 1 year13.0221.0762%
Returns for 3 years42.4768.4562%
Returns for 5 years24.5173.4833%
Returns for 10 years82.78251.2133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6